US futures indicate that markets are on course to open lower on Wednesday amid investor concerns surrounding the conflict in Ukraine and projections for US interest rates to climb to between 2.25% to 2.5%.
Oil, gold and Bitcoin were all trading higher on Wednesday morning.
Here are some of today’s trending stocks:
Draganfly (NASDAQ: DPRO)
This drone specialist’s shares climbed by more than 40% on Tuesday after it confirmed a new order for its Medical Response and Search and Rescue Drones from Coldchain Delivery Systems.
The drones will be deployed with Revived Soldiers Ukraine (RSU), a non-profit organization dedicated to providing aid to the people of Ukraine. The total initial order size up to 200 units of the American made drones.
In the immediate future, the company is supplying 10 drones and will additionally donate, three drone systems to RSU.
Draganfly’s medical drones can transport up to 35 pounds of medical supplies, including blood, pharmaceuticals, insulin/medicines, vaccines, water, and wound care kits, making delivery of life saving supplies a safer task for Ukrainian forces.
Rezolute Inc (NASDAQ: RZLT)
This biotechnology business appears poised to see its share price leap on Wednesday, with the price having jumped by nearly 30% in premarket trading.
This interest in Rezolute’s shares comes after the company announced positive data from its Phase 2b RIZE study of RZ358, a human monoclonal antibody that the company is championing as a therapy for conditions characterized by excessive insulin levels.
For now, the company merely confirmed that data from the study demonstrated the safety and tolerability of the therapy, adding that further results would be presented in the second quarter.
Sundial Growers Inc (NASDAQ: SNDL)
This cannabis stock looks set to move higher on Wednesday as part of what appears to be a flurry of interest in cannabis stocks.
The particular interest in Sundial Growers comes after good fourth quarter earnings from Nova Cannabis (TSE: NOVC), which Sundial is set to hold a majority stake in through its acquisition of Alcanna. Nova reported revenue growth of 176% and a 58% increase in gross profit.
Additionally, Sundial’s moment in the spotlight is coming amid wider interest in the cannabis space.
Fellow cannabis stocks like GrowGeneration Corp (NASDAQ: GRWG), American Green (OTCMKTS: ERBB) and Canopy Growth Corp (NASDAQ: CGC) were also generating chatter and trading higher ahead of the market open on Wednesday.
Investors looking for more details about Sundial won’t have to wait long, as the company’s next earnings release is expected on 30 March.
Zentek Ltd (NASDAQ: ZTEK)
Intellectual property development and commercialization specialist Zentek has seen its share jump by nearly 50% in premarket trading after the company was uplisted to the NASDAQ on Tuesday.
Zentek CEO, Greg Fenton, commented:
“Trading on the NASDAQ is an important milestone for Zentek, and reflective of our growth and transition to becoming a global technology company. This will be pivotal in generating additional interest and awareness in the US investment community, is expected to enhance trading liquidity in our shares, and will provide us with greater exposure to institutional investors.”
The uplisting has certainly boosted the company’s share price in the short term but the stock is still down by more than 30% across the year to date.
Creative Realities (NASDAQ: CREX)
Creative Realities stock looks set to leap on Wednesday. After all, the company’s stock is up by more than 30% ahead of the market open.
This comes after the digital solutions provider reported 5.6% revenue growth across the full year, with this being driven by more than 20% revenue growth from its digital signage offering.
Meanwhile, the company also swung from a net loss of $16.8m to a profit of $0.2m, with EBITDA also swapping from a loss of $13.9m to a profit of $3.9m.
CREX chief executive officer, Rick Mills, commented:
"We are proud of the work we have done to prepare the Company for long-term success and are excited about recent customer developments, both those we have previously announced and those we anticipate will come to fruition throughout 2022.
“Now more than ever, we believe our end-to-end offering has positioned CRI well within the industry to compete for new and growing opportunities with partners, particularly enterprise customers in a variety of key verticals."